Bernd Dörken
Charité - Universitätsmedizin Berlin(DE)
Publications by Year
Research Areas
Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment, Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments, CAR-T cell therapy research
Most-Cited Works
- → Oncogene-induced senescence as an initial barrier in lymphoma development(2005)1,195 cited
- → Senescence-associated reprogramming promotes cancer stemness(2017)1,088 cited
- → Reduced Treatment Intensity in Patients with Early-Stage Hodgkin's Lymphoma(2010)910 cited
- → Standard and Increased-Dose BEACOPP Chemotherapy Compared with COPP-ABVD for Advanced Hodgkin's Disease(2003)828 cited
- → Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells.(1997)765 cited
- Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors.(1996)
- → Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial(2012)622 cited